Intro

This chapter covers the Senate testimony of a Facebook whistleblower and the public relations strategies used by Facebook to discredit her. It also introduces a contentious report on Ginkgo Bioworks that claims fraudulent operations, prompting a critical look at its implications on the company's stock value.